Maxygen, Inc.   Report issue

For profit Phase 2
Founded: Redwood City CA United States (1996)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2007
NCT00501332
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Maxygen ApS | Maxygen Holdings Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

Filgrastim (neupogen) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Neutropenia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1